Một khung giám sát và công cụ định danh di truyền cho Klebsiella pneumoniae và các loài liên quan trong phức hợp

World Health Organisation. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics (2017).

Wyres, K. L. & Holt, K. E. Klebsiella pneumoniae as a key trafficker of drug resistance genes from environmental to clinically important bacteria. Curr. Opin. Microbiol. 45, 131–139 (2018).

Gorrie, C. L. et al. Gastrointestinal carriage is a major reservoir of K. pneumoniae infection in intensive care patients. Clin. Infect. Dis. 65, 208–215 (2017).

Martin, R. M. et al. Molecular epidemiology of colonizing and infecting isolates of Klebsiella pneumoniae. mSphere 1, e00261-16 (2016).

Chung, D. R. et al. Fecal carriage of serotype K1 Klebsiella pneumoniae ST23 strains closely related to liver abscess isolates in Koreans living in Korea. Eur. J. Clin. Microbiol. Infect. Dis. 31, 481–486 (2012).

Lin, Y.-T. et al. Seroepidemiology of Klebsiella pneumoniae colonizing the intestinal tract of healthy chinese and overseas chinese adults in Asian countries. BMC Microbiol. 12, 13 (2012).

Kaur, C. P., Vadivelu, J. & Chandramathi, S. Impact of Klebsiella pneumoniae in lower gastrointestinal tract diseases. J. Dig. Dis. 19, 262–271 (2018).

Podschun, R. & Ullmann, U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11, 589–603 (1998).

Petrosillo, N., Taglietti, F. & Granata, G. Treatment options for colistin resistant Klebsiella pneumoniae: present and future. J. Clin. Med. 8, 934 (2019).

Tooke, C. L. et al. β-Lactamases and β-lactamase inhibitors in the 21st century. J. Mol. Biol. 431, 3472–3500 (2019).

Geneva: World Health Organization. Prioritization of Pathogens To Guide Discovery, Research and Development of New Antibiotics for Drug-Resistant Bacterial Infections, Including Tuberculosis (2017).

Shon, A. S., Bajwa, R. P. S. & Russo, T. A. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae: a new and dangerous breed. Virulence 4, 107–118 (2013).

Siu, L. K., Yeh, K., Lin, J., Fung, C. & Chang, F. Klebsiella pneumoniae liver abscess: a new invasive syndrome. Lancet Infect. Dis. 12, 881–887 (2012).

Wyres, K. L. et al. Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae. PLoS Genet. 15, e1008114 (2019).

Brisse, S. et al. Virulent clones of Klebsiella pneumoniae: Identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS ONE 4, e4982 (2009).

Wyres, K. L., Lam, M. M. C. & Holt, K. E. Population genomics of Klebsiella pneumoniae. Nat. Rev. Microbiol. 18, 344–359 (2020).

Walker, K. A. et al. A Klebsiella pneumoniae regulatory mutant has reduced capsule expression but retains hypermucoviscosity. MBio 10, e00089–19 (2019).

Walker, K. A., Treat, L. P., Sepúlveda, V. E. & Miller, V. L. The small protein RmpD drives hypermucoviscosity in Klebsiella pneumoniae. MBio 11, e01750–20 (2020).

Holt, K. E. et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc. Natl Acad. Sci. USA 112, E3574–81 (2015).

Gu, D. et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect. Dis. 18, 37–46 (2018).

Xu, M. et al. High prevalence of KPC-2-producing hypervirulent Klebsiella pneumoniae causing meningitis in Eastern China. Infect. Drug Resist. 12, 641–653 (2019).

Dong, N. et al. Genome analysis of clinical multilocus sequence Type 11 Klebsiella pneumoniae from China. Microb. Genomics 4, e000149 (2018).

Wong, M. H. Y. et al. Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect. Dis. 18, 24 (2018).

Yao, H., Qin, S., Chen, S., Shen, J. & Du, X.-D. Emergence of carbapenem-resistant hypervirulent Klebsiella pneumoniae. Lancet Infect. Dis. 18, 25 (2018).

Ørskov, I. D. A. & Fife-Asbury, M. A. New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int J. Syst. Bacteriol. 27, 386–387 (1977).

Trautmann, M. et al. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin. Diagn. Lab. Immunol. 4, 550–555 (1997).

Elhani, D. et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains in a university hospital in Tunis, Tunisia, 1999-2005. Clin. Microbiol. Infect. 16, 157–164 (2010).

Chen, L. et al. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol. 22, 686–696 (2014).

Diancourt, L., Passet, V., Verhoef, J., Grimont, P. A. & Brisse, S. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43, 4178–4182 (2005).

Wyres, K. L. & Holt, K. E. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trend Microbiol. 24, 944–956 (2016).

Long, S. W. et al. Population genomic analysis of 1,777 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307. MBio 8, e00489–17 (2017).

Potter, R. F. et al. Population structure, antibiotic resistance, and uropathogenicity of Klebsiella variicola. MBio 9, e02481–18 (2018).

David, S. et al. Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread. Nat. Microbiol. https://doi.org/10.1038/s41564-019-0492-8 (2019).

Lam, M. M. C. et al. Genetic diversity, mobilisation and spread of the yersiniabactin-encoding mobile element ICEKp in Klebsiella pneumoniae populations. Microb. Genom. 9, e000196 (2018).

Lam, M. C. C. et al. Tracking key virulence loci encoding aerobactin and salmochelin siderophore synthesis in Klebsiella pneumoniae. Genome Med. 10, 77 (2018).

Wick, R. R., Heinz, E., Holt, K. E. & Wyres, K. L. Kaptive Web: user-friendly capsule and lipopolysaccharide serotype prediction for Klebsiella genomes. J. Clin. Microbiol. 56, e00197–18 (2018).

Martínez-Romero, E. et al. Genome misclassification of Klebsiella variicola and Klebsiella quasipneumoniae isolated from plants, animals and humans. Salud Publica Mex. 60, 52–62 (2018).

Rodrigues, C. et al. Description of Klebsiella africanensis sp. nov., Klebsiella variicola subsp. tropicalensis subsp. nov. and Klebsiella variicola subsp. variicola subsp. nov. Res. Microbiol. S0923-2508, 30019–1 (2019).

Long, S. W. et al. Whole-genome sequencing of a human clinical isolate of the novel species Klebsiella quasivariicola sp. nov. Genome Announc. 5, e01057–17 (2017).

Ondov, B. D. et al. Mash: fast genome and metagenome distance estimation using MinHash. Genome Biol. 17, 132 (2016).

Fajardo-Lubia´n, A., Ben Zakour, N. L., Agyekum, A., Qi, Q. & Iredell, J. R. Host adaptation and convergent evolution increases antibiotic resistance without loss of virulence in a major human pathogen. PLoS Pathog. 15, e1007218 (2019).

Wong, J. L. C. et al. OmpK36-mediated carbapenem resistance attenuates ST258 Klebsiella pneumoniae in vivo. Nat. Commun. 10, 3957 (2019).

Hauck, C. et al. Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections. Clin. Microbiol. Infect. 22, 513–519 (2016).

Opoku-Temeng, C., Kobayashi, S. D. & DeLeo, F. R. Klebsiella pneumoniae capsule polysaccharide as a target for therapeutics and vaccines. Comput. Struct. Biotechnol. J. 17, 1360–1366 (2019).

Venturini, C. et al. Fine capsule variation affects bacteriophage susceptibility in Klebsiella pneumoniae ST258. FASEB J. 34, 10801–10817 (2020).

Pan, Y.-J. et al. Identification of three podoviruses infecting Klebsiella encoding capsule depolymerases that digest specific capsular types. Microb. Biotechnol. 12, 472–486 (2019).

de Sousa, J. A. M., Buffet, A., Haudiquet, M., Rocha, E. P. C. & Rendueles, O. Modular prophage interactions driven by capsule serotype select for capsule loss under phage predation. ISME J. 14, 2980–2996 (2020).

Arena, F. et al. Population structure of KPC carbapenemase-producing Klebsiella pneumoniae in a long-term acute-care rehabilitation facility: identification of a new lineage of clonal group 101, associated with local hyperendemicity. Microb. Genom. 6, e000308 (2020).

Ferrari, C. et al. Multiple Klebsiella pneumoniae KPC clones contribute to an extended hospital outbreak. Front. Microbiol. 10, 2767 (2019).

Magiorakos, A.-P. et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18, 268–281 (2012).

Wyres, K. L. et al. Genomic surveillance for hypervirulence and multi-drug resistance in invasive Klebsiella pneumoniae from South and Southeast Asia. Genome Med. 12, 11 (2020).

Heinz, E., Brindle, R., Morgan-McCalla, A., Peters, K., & Thomson, N. R. Caribbean multi-centre study of Klebsiella pneumoniae: whole-genome sequencing, antimicrobial resistance and virulence factors. Microb. Genom. 5,e000266 (2019).

Musicha, P. et al. Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages. J. Antimicrob. Chemother. 74, 1223–1232 (2019).

Alvarez-Uria, G., Gandra, S., Mandal, S. & Laxminarayan, R. Global forecast of antimicrobial resistance in invasive isolates of Escherichia coli and Klebsiella pneumoniae. Int. J. Infect. Dis. 68, 50–53 (2018).

Brolund, A. et al. Worsening epidemiological situation of carbapenemase-producing Enterobacteriaceae in Europe, assessment by national experts from 37 countries, July 2018. Eurosurveillance 24, 1900123 (2019).

Coombs G. et al. on behalf of the Australian Group on Antimicrobial Resistance and Australian Commission on Safety and Quality in Health Care. Australian Group on Antimicrobial Resistance Sepsis Outcomes Programs: 2019 Report. Sydney: ACSQHC; 2021.

Kidd, T. J. et al. Molecular mechanisms and virulence of colistin-resistant Klebsiella pneumoniae. Eur. Respir. J. 48, PA2625 (2016).

Cannatelli, A. et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob. Agents Chemother. 58, 5696 LP–5703 (2014).

Cannatelli, A. et al. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment. Antimicrob. Agents Chemother. 58, 4399–4403 (2014).

Yu, W.-L., Lee, M.-F., Tang, H.-J., Chang, M.-C. & Chuang, Y.-C. Low prevalence of rmpA and high tendency of rmpA mutation correspond to low virulence of extended spectrum β-lactamase-producing Klebsiella pneumoniae isolates. Virulence 6, 162–172 (2015).

Chen, L. & Kreiswirth, B. N. Convergence of carbapenem-resistance and hypervirulence in Klebsiella pneumoniae. Lancet Infect. Dis. 18, 2–3 (2018).

Lam, M. M. C. et al. Convergence of virulence and multidrug resistance in a single plasmid vector in multidrug-resistant Klebsiella pneumoniae ST15. J. Antimicrob. Chemother. https://doi.org/10.1093/jac/dkz028 (2019).

Chen, Y. et al. Preterm infants harbour diverse Klebsiella populations, including atypical species that encode and produce an array of antimicrobial resistance- and virulence-associated factors. Microb. Genomics 6, e000377 (2020).

Shao, Y. et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature 574, 117–121 (2019).

Agyekum, A. et al. Predictability of phenotype in relation to common β-lactam resistance mechanisms in Escherichia coli and Klebsiella pneumoniae. J. Clin. Microbiol. 54, 1243–1250 (2016).

Ginn, A. N. et al. Limited diversity in the gene pool allows prediction of third-generation cephalosporin and aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae. Int. J. Antimicrob. Agents 42, 19–26 (2013).

Ginn, A. N. et al. Prediction of major antibiotic resistance in Escherichia coli and Klebsiella pneumoniae in Singapore, USA and China using a limited set of gene targets. Int. J. Antimicrob. Agents 43, 563–565 (2014).

Stoesser, N. et al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J. Antimicrob. Chemother. 68, 2234–2244 (2013).

Clausen, P. T. L. C., Zankari, E., Aarestrup, F. M. & Lund, O. Benchmarking of methods for identification of antimicrobial resistance genes in bacterial whole genome data. J. Antimicrob. Chemother. 71, 2484–2488 (2016).

Bachman, M. A. et al. Klebsiella pneumoniae yersiniabactin promotes respiratory tract infection through evasion of lipocalin 2. Infect. Immun. 79, 3309–3316 (2011).

Nougayrède, J. P. et al. Escherichia coli induces DNA double-strand breaks in eukaryotic cells. Science 313, 848–851 (2006).

Russo, T. A., Olson, R., Macdonald, U., Beanan, J. & Davidson, B. A. Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo. Infect. Immun. 83, 3325–3333 (2015).

Russo, T. A. et al. Identification of biomarkers for the differentiation of hypervirulent Klebsiella pneumoniae from classical K. pneumoniae. J. Clin. Microbiol. 56, e00776-18 (2018).

Konopka, K., Bindereif, A. & Neilands, J. B. Aerobactin-mediated utilization of transferrin iron. Biochemistry 21, 6503–6508 (1982).

Lam, M. M. C. et al. Population genomics of hypervirulent Klebsiella pneumoniae clonal-group 23 reveals early emergence and rapid global dissemination. Nat. Commun. 9, 2703 (2018).

Drlica, K. & Zhao, X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol. Mol. Biol. Rev. 61, 377–392 (1997).

Brisse, S. et al. wzi Gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J. Clin. Microbiol. 51, 4073–4078 (2013).

Wick, R. R., Judd, L. M., Gorrie, C. & Holt, K. E. Unicycler: Resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput. Biol. 13, e1005595 (2017).

Nurk, S., Meleshko, D., Korobeynikov, A. & Pevzner, P. A. metaSPAdes: a new versatile metagenomic assembler. Genome Res. 27, 824–834 (2017).

Wu, Y.-W., Simmons, B. A. & Singer, S. W. MaxBin 2.0: an automated binning algorithm to recover genomes from multiple metagenomic datasets. Bioinformatics 32, 605–607 (2016).

Wood, D. E., Lu, J. & Langmead, B. Improved metagenomic analysis with Kraken 2. Genome Biol. 20, 257 (2019).

Lu, J., Bretwieser, F. P., Thielen, P. & Salzberg, S. L. Bracken: estimating species abundance in metagenomics data. PeerJ. Comput. Sci. 3, e104 (2017).

Parks, D. H. et al. A complete domain-to-species taxonomy for Bacteria and Archaea. Nat. Biotechnol. 38, 1079–1086 (2020).

Lam, M. M. C. et al. A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. Kleborate v2.0.0 https://doi.org/10.5281/zenodo.4923015 (2020).

Bialek-davenet, S. et al. Genomic definition of hypervirulent and multidrug-resistant Klebsiella pneumoniae clonal groups. Emerg. Infect. Dis. 20, 1812–1820 (2014).

Neubauer, S. et al. A Genotype-phenotype correlation study of SHV β-lactamases offers new insight into SHV resistance profiles. Antimicrob. Agents Chemother. 64, e02293–19 (2020).